EUVIMEDEUVIMED entdecken
Crossref

Serum pepsinogen combined with computed tomography imaging for diagnosing recurrence of gastric cancer after total gastrectomy

Jiu-Ru Zhang, Xue-Wen Xu, Jia-Meng Liu, Zhi-Hong Zhu, Chao-Ming Mao

World Journal of Gastroenterology · 14.01.2027 · 33 (2)

DOI: 10.3748/wjg.124537 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Gastroenterology, online erschienen am 14.01.2027. Verfasst von Jiu-Ru Zhang und 4 weiteren Autor:innen. Die Arbeit nennt 29 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Serum pepsinogen (PG) is a potential biomarker for monitoring recurrence after total gastrectomy for gastric cancer (GC). Computed tomography (CT) imaging provides anatomical localization but has limited sensitivity for early recurrence. The complementary value of combining these two modalities and the impact of tumor differentiation on the diagnostic performance of PG require systematic evaluation. AIM To evaluate the combined diagnostic value of serum PG and CT imaging for recurrence after total gastrectomy, and to assess the impact of histological differentiation on PG-based diagnosis. METHODS Data from 110 patients who underwent radical total gastrectomy for GC were retrospectively analyzed. Using a comprehensive reference standard, positivity rates of serum PG levels and CT imaging for recurrence were compared. Receiver operating characteristic curves were generated to assess the individual diagnostic performance of each modality, and a combined predictive model was developed using multivariate logistic regression. Immunohistochemistry was performed to examine PG expression in tumor tissues and its relationship with histological differentiation and serum PG levels. RESULTS During the 1-year post-operative follow-up, recurrence was confirmed in 65 patients (59.09%). The positivity rate of serum PG was significantly higher than CT imaging overall (56.36% vs 40.00%; P = 0.0027) and in the recurrence subgroup (92.31% vs 63.08%; P = 0.0008). The area under the curve (AUC) for serum PG alone was 0.94, whereas that for CT imaging alone was 0.78. The combined logistic regression model achieved an AUC of 0.98. Both serum PG [odds ratio (OR) = 501.25; P < 0.0001] and CT imaging (OR = 58.22; P = 0.001) were independent predictors of recurrence. PG expression was higher in undifferentiated than in differentiated tumors (86.36% vs 14.29%; P = 0.0011). After excluding PG-negative differentiated recurrences, serum PG sensitivity increased from 92.31% to 98.36%. CONCLUSION Serum PG and CT imaging play complementary roles in functional assessment and morphological localization. Integrating these modalities with histological stratification provides a highly sensitive tool for diagnosing post-gastrectomy recurrence and supports personalized postoperative surveillance.

Zitieren

APA

Zhang, J., Xu, X., Liu, J., Zhu, Z., & Mao, C. (2027). Serum pepsinogen combined with computed tomography imaging for diagnosing recurrence of gastric cancer after total gastrectomy. World Journal of Gastroenterology, 33(2). https://doi.org/10.3748/wjg.124537

Vancouver

Zhang J, Xu X, Liu J, Zhu Z, Mao C. Serum pepsinogen combined with computed tomography imaging for diagnosing recurrence of gastric cancer after total gastrectomy. World Journal of Gastroenterology. 2027;33(2). doi:10.3748/wjg.124537

BibTeX
@article{Zhang2027,
  author = {Zhang, Jiu-Ru and Xu, Xue-Wen and Liu, Jia-Meng and Zhu, Zhi-Hong and Mao, Chao-Ming},
  title = {Serum pepsinogen combined with computed tomography imaging for diagnosing recurrence of gastric cancer after total gastrectomy},
  journal = {World Journal of Gastroenterology},
  year = {2027},
  volume = {33},
  number = {2},
  doi = {10.3748/wjg.124537}
}
Kostenlos starten →